DiaSorin

Stevanato Group appoints Ugo Gay as Chief Operations Officer

Retrieved on: 
Thursday, April 4, 2024
Medical Supplies, Medical Devices, Health, Other Health, Pharmaceutical, Biotechnology, Organization, DiaSorin, Growth, Stevanato Group, Information, Piombino Dese, Ugo, Investment, Multimedia, Development, Management

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life science industries, today announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).

Key Points: 
  • Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life science industries, today announced the appointment of Ugo Gay as its new Chief Operations Officer (COO).
  • View the full release here: https://www.businesswire.com/news/home/20240404727049/en/
    Ugo Gay appointed as Chief Operations Officer of Stevanato Group (Photo: Business Wire)
    The addition of Ugo Gay underscores Stevanato Group’s unwavering commitment to driving operational efficiency, process standardization, and sustainable growth across its global value chain.
  • Ugo Gay brings to Stevanato Group nearly three decades of experience in industry, business management, supply chain, and operations.
  • “I am honored to help lead Stevanato Group's journey towards operational excellence, driving sustainable growth across our global footprint while fostering innovation," said Ugo Gay, Chief Operations Officer at Stevanato Group.

Global Covid-19 Diagnostic Market Research 2024 with Executive and Consultant Guides - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Technology, Medical Devices, Infectious Diseases, Hospitals, Science, Genetics, Medical Supplies, FDA, Biotechnology, COVID-19, Health, Health Technology, Other Science, Research, Nanotechnology, Pharmaceutical, Stem Cells, Phosphorus, DiaSorin, COVID

6.7 NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests

Key Points: 
  • 6.7 NanoDx Prepares for POC Platform Commercialization With TBI, COVID Tests
    6.21 Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
    6.23 Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
    6.27 DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
    6.34 FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests

Global COVID-19 Diagnostics Market Report 2024: Assay Volumes and 5-Year Market Size Outlook - As Pandemic Testing Winds Down, a New Very Large Market for Diagnostics is Emerging - ResearchAndMarkets.com

Retrieved on: 
Monday, March 4, 2024
Infectious Diseases, Health, Medical Supplies, FDA, DiaSorin, Phosphorus

5.3 Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay

Key Points: 
  • 5.3 Novacyt Gets CE Mark for Multigene SARS-CoV-2 Test, Launches RUO Variant Assay
    5.5 Phosphorus Diagnostics Gets EUA for DTC C19 Test, Sample Collection Kit
    5.9 DiaSorin Acquires Luminex to Broaden MDx Portfolio, Expand US Presence
    5.16 FDA Grants EUAs for DTC Sample Collection Kit, Two Molecular Tests

In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026 | The rising geriatric population with chronic and infectious diseases drives the market growth - Technavio

Retrieved on: 
Wednesday, December 13, 2023
Abbott Laboratories, Sample, Thermo Fisher Scientific, Prevalence, DiaSorin, Immunoassay, ROW, Hepatitis B virus, BGI Group, Laboratory, Patient, HBV, Mindful Scientific Inc., Danaher Corporation, Infection, Illumina, Inc., Quest Diagnostics, Virus, Cancer, Ageing, HCV, QIAGEN, IVD, Diabetes, Agilent Technologies, Retail, Medical device, Hematology, Geography

NEW YORK, Dec. 12, 2023 /PRNewswire/ -- The in-vitro diagnostic market size is estimated to grow by USD 33.16 billion from 2021 to 2026.

Key Points: 
  • NEW YORK, Dec. 12, 2023 /PRNewswire/ -- The in-vitro diagnostic market size is estimated to grow by USD 33.16 billion from 2021 to 2026.
  • The rising geriatric population with chronic and infectious diseases drives the in-vitro diagnostics (IVD) market growth during the forecast period.
  • Hence, the increasing prevalence of diseases in the aging population is expected to drive market growth during the forecast period.
  • Key challenges - Stringent regulatory guidelines for in-vitro diagnostics manufacturers can pose a significant threat which can hinder the in-vitro diagnostics (IVD) market growth during the forecast period.

Automated Liquid Handling Technologies Market Size to Expand Lucratively and Reach $4.31 Bn to 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Friday, December 8, 2023
Agilent Technologies, Automaton, Research, Conditional sentence, DiaSorin, Projection, Clinical trial, Gold, PCR, Element, Analytik Jena, Laboratory, Workflow, Automation, Drug discovery, Drug development, Partnership, Bravo, NGS, QIAGEN, TB, 3D printing, Fine chemical, Tecan

Key Developments In The Market:

Key Points: 
  • Key Developments In The Market:
    In Feb 2023, Agilent Technologies Inc. unveiled an on-deck thermal cycler (ODTC) for their Agilent Bravo NGS automated liquid handling platform.
  • In December 2021, Flow Robotics A/S and Automata collaborated to offer end-to-end liquid handling automation in laboratories with the pipetting robot, flowbot® ONE, and the robot arm, Eva.
  • For instance, in July 2022, Analytik Jena expanded its range of interchangeable pipetting heads for the fully automated liquid handling platform CyBio FeliX.
  • Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on product

Automated Liquid Handling Technologies Market Size to Expand Lucratively and Reach $4.31 Bn to 2031 - Explained Details | Updated InsightAce Study

Retrieved on: 
Friday, December 8, 2023
Agilent Technologies, Automaton, Research, Conditional sentence, DiaSorin, Projection, Clinical trial, Gold, PCR, Element, Analytik Jena, Laboratory, Workflow, Automation, Drug discovery, Drug development, Partnership, Bravo, NGS, QIAGEN, TB, 3D printing, Fine chemical, Tecan

Key Developments In The Market:

Key Points: 
  • Key Developments In The Market:
    In Feb 2023, Agilent Technologies Inc. unveiled an on-deck thermal cycler (ODTC) for their Agilent Bravo NGS automated liquid handling platform.
  • In December 2021, Flow Robotics A/S and Automata collaborated to offer end-to-end liquid handling automation in laboratories with the pipetting robot, flowbot® ONE, and the robot arm, Eva.
  • For instance, in July 2022, Analytik Jena expanded its range of interchangeable pipetting heads for the fully automated liquid handling platform CyBio FeliX.
  • Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on product

Global Rapid Influenza Diagnostic Tests Market to Surpass $2.20 Billion by 2030 - CoherentMI

Retrieved on: 
Wednesday, December 6, 2023
QuidelOrtho, Pharynx, Thermo Fisher Scientific, Abbott Laboratories, Prevalence, DiaSorin, BD (company), Collection, Patient, Urinary tract infection, PerkinElmer, CE, Diagnosis, End user, Growth, Telehealth, Luminex Corporation, Vaccine

Two key trends can be observed in the global rapid influenza diagnostic tests market.

Key Points: 
  • Two key trends can be observed in the global rapid influenza diagnostic tests market.
  • Increasing demand for rapid influenza diagnostic tests: The global rapid influenza diagnostic tests market is anticipated to witness significant growth during the forecast period of 2023-2030.
  • Read complete market research report, " Global Rapid Influenza Diagnostic Tests Market Size And Share Analysis - Growth Trends And Forecasts (2023 - 2030) ", Published by CoherentMI.
  • In conclusion, the global rapid influenza diagnostic tests market is expected to witness significant growth due to the increasing demand for quick and accurate diagnosis of influenza.

Global Rapid Influenza Diagnostic Tests Market to Surpass $2.20 Billion by 2030 - CoherentMI

Retrieved on: 
Wednesday, December 6, 2023
QuidelOrtho, Pharynx, Thermo Fisher Scientific, Abbott Laboratories, Prevalence, DiaSorin, BD (company), Collection, Patient, Urinary tract infection, PerkinElmer, CE, Diagnosis, End user, Growth, Telehealth, Luminex Corporation, Vaccine

Two key trends can be observed in the global rapid influenza diagnostic tests market.

Key Points: 
  • Two key trends can be observed in the global rapid influenza diagnostic tests market.
  • Increasing demand for rapid influenza diagnostic tests: The global rapid influenza diagnostic tests market is anticipated to witness significant growth during the forecast period of 2023-2030.
  • Read complete market research report, " Global Rapid Influenza Diagnostic Tests Market Size And Share Analysis - Growth Trends And Forecasts (2023 - 2030) ", Published by CoherentMI.
  • In conclusion, the global rapid influenza diagnostic tests market is expected to witness significant growth due to the increasing demand for quick and accurate diagnosis of influenza.

In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic and infectious diseases drives the market growth- Technavio

Retrieved on: 
Monday, December 4, 2023
Abbott Laboratories, Sample, Thermo Fisher Scientific, Prevalence, DiaSorin, Immunoassay, ROW, Hepatitis B virus, BGI Group, Laboratory, Patient, HBV, Mindful Scientific Inc., Danaher Corporation, Infection, Illumina, Inc., Quest Diagnostics, Virus, Cancer, Ageing, HCV, QIAGEN, IVD, Diabetes, Agilent Technologies, Retail, Medical device, Hematology, Geography

NEW YORK, Dec. 3, 2023 /PRNewswire/ -- The in-vitro diagnostic market size is estimated to grow by USD 33.16 billion from 2021 to 2026.

Key Points: 
  • NEW YORK, Dec. 3, 2023 /PRNewswire/ -- The in-vitro diagnostic market size is estimated to grow by USD 33.16 billion from 2021 to 2026.
  • The rising geriatric population with chronic and infectious diseases drives the in-vitro diagnostics (IVD) market growth during the forecast period.
  • Hence, the increasing prevalence of diseases in the aging population is expected to drive market growth during the forecast period.
  • The in-vitro diagnostics market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.

Pattern Bioscience Strengthens Leadership Team with Key Appointments

Retrieved on: 
Tuesday, October 17, 2023
Health Technology, Technology, Nanotechnology, Stem Cells, Pharmaceutical, Professional Services, General Health, Infectious Diseases, Science, Biotechnology, Software, Data Analytics, Other Science, Health, Research, Diagnosis, MBA, Infection, Veteran, University, Machine learning, Moses Austin, Single-cell analysis, Luminex Corporation, DiaSorin, Economics, Disruptive innovation, Organization, Medical laboratory, Quality control, AACC, American Airlines, BS, Patient, BA, Microbiology, Accounting, Pneumonia, McKesson Corporation, CFO, Treasury, Global health, Pharmaceutical industry, Vaccine, Operation, Symantec

“Tim and Travis join us at a transformative moment in our quest to set a new standard in infectious disease diagnostics,” said Nick Arab, co-founder and CEO of Pattern Bioscience.

Key Points: 
  • “Tim and Travis join us at a transformative moment in our quest to set a new standard in infectious disease diagnostics,” said Nick Arab, co-founder and CEO of Pattern Bioscience.
  • “We are proud to add two proven veterans to our team as the company expands from development to validation and commercialization.
  • Pattern Bioscience is pioneering the use of single-cell microbiology to rapidly diagnose drug-resistant bacterial infections and identify effective treatments.
  • “Pattern Bioscience is redefining the speed and performance of bacterial diagnostics to help better address the growing threat of antibiotic resistance,” said Mr. Skansi.